Global Branded PAH Therapeutics Market Set to Reach $9.86 Billion by 2029: Analysis by Drug Class, Route of Administration, Distribution Channel, Region and Country
January 30, 2024 04:56 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country:...
Insights on the Pulmonary Arterial Hypertension (PAH) Drugs Global Market to 2027: Increasing Prevalence of Cardiovascular and Pulmonary Disorders Drives Growth
February 03, 2023 04:58 ET
|
Research and Markets
Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension (PAH) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been...
Global Pulmonary Arterial Hypertension (PAH) Drugs Market Report 2020: Increasing Awareness Regarding Available Treatment Alternatives to Drive Market Growth
December 01, 2020 05:18 ET
|
Research and Markets
Dublin, Dec. 01, 2020 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension (PAH) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been...